• 011-26907444
  • raghava@iiitd.ac.in

Browse result page of AntiTbPdb

The total number entries retrieved from this search are 550
IDNameSequenceN-Terminal ModificationC-Terminal ModificationChemical ModificationLinear/CyclicLengthChiralityNatureSourceOriginSpeciesStrainInhibition ConcentrationIn vitro/ In vivoCell LineIntracellular InhibitionCytotoxicityAnimal ModelEffective Dose in model organismImmune ResponceMechanism of ActionTargetCombination TherapyOther ActivitiesYear of PublicationPubmed ID/ Patent No.
antitb_1656Trichoderins Bnot availableNANANANA0NANANaturalTrichoderma speciesMycobacterium tuberculosisMycobacterium tuberculosis H37Rv (aerobic)IC90= 0.63 μg/mlin vitroHuman THP-1 cell linesNANANA NANAMicrobial membrane disruptionNANANA201020483615
antitb_1659Trichoderins Bnot availableNANANANA0NANANaturalTrichoderma speciesMycobacterium tuberculosisMycobacterium tuberculosis H37Rv (hypoxic)IC90= 0.63 μg/mlin vitroHuman THP-1 cell linesNANANA NANAMicrobial membrane disruptionNANANA201020483615
antitb_1662Trichoderins Bnot availableNANANANA0NANANaturalTrichoderma speciesMycobacterium tuberculosisMycobacterium tuberculosis H37Rv (aerobic)IC90= 0.02 μg/mlin vitroHuman THP-1 cell linesNANANA NANAMicrobial membrane disruptionNANANA201020483615
antitb_1665Trichoderins Bnot availableNANANANA0NANANaturalTrichoderma speciesMycobacterium tuberculosisMycobacterium tuberculosis H37Rv (hypoxic)IC90= 0.02 μg/mlin vitroHuman THP-1 cell linesNANANA NANAMicrobial membrane disruptionNANANA201020483615
antitb_1668Trichoderins Bnot availableNANANANA0NANANaturalTrichoderma speciesMycobacterium tuberculosisMycobacterium tuberculosis H37Rv (aerobic)IC90= 0.13 μg/mlin vitroHuman THP-1 cell linesNANANA NANAMicrobial membrane disruptionNANANA201020483615
antitb_1671Trichoderins Bnot availableNANANANA0NANANaturalTrichoderma speciesMycobacterium tuberculosisMycobacterium tuberculosis H37Rv (hypoxic)IC90= 0.13 μg/mlin vitroHuman THP-1 cell linesNANANA NANAMicrobial membrane disruptionNANANA201020483615
antitb_1679TL-119not availableNANANoneNA0NANANaturalBacillus species, strain TL-119Mycobacterium Tuberculosis Mycobacterium tuberculosis H37RvMIC = >50 μg/mlin vitroNANANANA NANANANANAAntibacterial against Bacillus subtilis PCI 219, Staphylococcus aureus FDA 209P JC-1, Staphylococcus aureus Smith, Diplococcus pneumoniae type I, Streptococcus pyogenes C-203, Escherichia coli NIHJ JC-2, Klebsiella pneumoniae, Salmonella typhimurium, Pseudomonas aeruginosa Ps 2419741112764
antitb_168061-26not availableNANANoneNA0NAWeakly basicNaturalBacillus, strain 61-26,Mycobacterium TuberculosisMycobacterium tuberculosis H37RvMIC = >50 μg/mlin vitroNANANANA NANANANANAAntibacterial against Bacillus subtilis PCI 219, Bacillus anthracis, Staphylococcus aureus FDA 209P JC-1, Staphylococcus aureus Smith, Diplococcus pneumoniae type I, Streptococcus pyogenes C-203, Escherichia coli NIHJ JC-2, Klebsiella pneumoniae, Salmonella typhimurium And Antifungal against Candida albicans M-9, Trichophyton rubrum, Trichophyton mentagrophytes19741112765
antitb_1683S35-Siomycinnot availableNANANoneNA0NANANaturalStreptomyces sioyaensisMycobacterium tuberculosisMycobacterium tuberculosisNAin vitroNANANANA NANANANANAmany clinical resistant strains of Staphylococcus19724630599
antitb_1684Jolipeptinnot availableNANANoneNA0NANANaturalBacillus polymyxa var. colistinus KoyamaMycobacterium Tuberculosis Mycobacterium tuberculosis 607MIC = 10 μg/mLin vitroNANANANA NANANANANAAntibacterial against E. coli B, E. coli NIHJ, Staphylococcus aureus FDA 209P, Bacillus subtilis PCI 219, Micrococcus lysodeihticus19725042449
antitb_1685S-520not availableNANANoneNA0NANANaturalStreptomyces diastaticusMycobacterium TuberculosisMycobacterium tuberculosis 607MIC = 100 μg/mlin vitroNANANANA NANANANANAAntibacterial against Bacillus subtilis, Bacillus anthracis, Staphylococcus aureus, Staphylococcus aureus,Streptococcus pyogenes,Diplococcus pneumoniae, Sarcinalutea Corynebacterium diphtheriae19705459623
antitb_1702Human neutrophil peptide (HNP-1)ACYCRIPACIAGERRYGTCIYQGRLWAFCCFreeFreeDisulphide linkage between cys2-cys30, cys4-cys19,cys9-cys29Cyclic30LCationicNaturalHuman neutrophil Mycobacterium tuberculosis Mycobacterium tuberculosis Ra 7632GReduction in CFU at 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1703Human neutrophil peptide (HNP-1)ACYCRIPACIAGERRYGTCIYQGRLWAFCCFreeFreeDisulphide linkage between cys2-cys30, cys4-cys19,cys9-cys30Cyclic30LCationicNaturalHuman neutrophil Mycobacterium tuberculosis Mycobacterium tuberculosis Ra 9034GReduction in CFU at 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1704Human neutrophil peptide (HNP-1)ACYCRIPACIAGERRYGTCIYQGRLWAFCCFreeFreeDisulphide linkage between cys2-cys30, cys4-cys19,cys9-cys31Cyclic30LCationicNaturalHuman neutrophil Mycobacterium tuberculosis Mycobacterium tuberculosis Ra 11170GReduction in CFU at 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1705Synthetic rabbit neytrophil (SNP-1)not availableNANANANA0NACationicNaturalRabbit neutrophilMycobacterium tuberculosis Mycobacterium tuberculosis Ra 7632G5Reduction in CFU at 0 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1706Synthetic rabbit neytrophil (SNP-1)not availableNANANANA0NACationicNaturalRabbit neutrophilMycobacterium tuberculosis Mycobacterium tuberculosis Ra 9034GReduction in CFU at 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1707Synthetic rabbit neytrophil (SNP-1)not availableNANANANA0NACationicNaturalRabbit neutrophilMycobacterium tuberculosis Mycobacterium tuberculosis Ra 11170GReduction in CFU at 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1708Porcine leucocyte peptide (PG-1)RGGRLCYCRRRFCVCVGRFreeFreeDisulphide linkage 6-15 and 8-13Cyclic18LCationicNatural porcine neutrophil leucocyteMycobacterium tuberculosis Mycobacterium tuberculosis Ra 7632GReduction in CFU at 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1709Porcine leucocyte peptide (PG-1)RGGRLCYCRRRFCVCVGRFreeFreeDisulphide linkage 6-15 and 8-14Cyclic18LCationicNatural porcine neutrophil leucocyteMycobacterium tuberculosis Mycobacterium tuberculosis Ra 9034GReduction in CFU at 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1710Porcine leucocyte peptide (PG-1)RGGRLCYCRRRFCVCVGRFreeFreeDisulphide linkage 6-15 and 8-15Cyclic18LCationicNatural porcine neutrophil leucocyteMycobacterium tuberculosis Mycobacterium tuberculosis Ra 11170GReduction in CFU at 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1711Porcine leucocyte peptide (PG-1)RGGRLCYCRRRFCVCVGRFreeFreeDisulphide linkage 6-15 and 8-16Cyclic18LCationicNatural porcine neutrophil leucocyteMycobacterium tuberculosis Mycobacterium tuberculosis H37 RaIC50= 5 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1712Porcine leucocyte peptide (PG-1)RGGRLCYCRRRFCVCVGRFreeFreeDisulphide linkage 6-15 and 8-17Cyclic18LCationicNatural porcine neutrophil leucocyteMycobacterium tuberculosis Mycobacterium tuberculosis H37 RaMIC = 50 μg/mlin vitroNANANANA NANAMicrobial membrane disruptionNANANA19968641802
antitb_1713Ecumicin(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)FreeFreeN-methylation pattern, N-Me-Val = N-methyl-valine, N,N-Me2-Val = N,N-dimethyl-valine, N-Me-Thr = N-methyl-threonine, N-Me-Leu = N-methyl-leucine, N-Me-allo-Ilu = N-methyl-isoleucine, N-Me-4-OMe-Trp = N-methyl-4-methoxy-tryptophan, Ph-threo-Ser = PheMacrocyclic 13LNANaturalProduced by a genetically distinct Nonomuraea species, strain MJM5123Mycobacterium tuberculosis Mycobacterium Tuberculosis H37Rv resistant to streptomycinIC90= < 0.20 μg/mlBothVERO cell line50 % bacteria is killed No cytotoxicityNA NANANANANANA201425409285
antitb_1714Ecumicin(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)FreeFreeN-methylation pattern, N-Me-Val = N-methyl-valine, N,N-Me2-Val = N,N-dimethyl-valine, N-Me-Thr = N-methyl-threonine, N-Me-Leu = N-methyl-leucine, N-Me-allo-Ilu = N-methyl-isoleucine, N-Me-4-OMe-Trp = N-methyl-4-methoxy-tryptophan, Ph-threo-Ser = PheMacrocyclic 13LNANaturalProduced by a genetically distinct Nonomuraea species, strain MJM5124Mycobacterium tuberculosis Mycobacterium Tuberculosis H37Rv resistant to rifampicinIC90= 0.30 μg/mlBothVERO cell line51 % bacteria is killed No cytotoxicityNA NANANANANANA201425409285
antitb_1715Ecumicin(N,N-Me2-Val)-(Val)-(N-Me-allo-Ilu)-(Thr)-(N-Me-Thr)-(Val)-(N-Me-Leu)-(Val)-(N-Me-Val)-(N-Me-4-OMe-Trp)-(Val)-(Ph-threo-Ser)-(Val)FreeFreeN-methylation pattern, N-Me-Val = N-methyl-valine, N,N-Me2-Val = N,N-dimethyl-valine, N-Me-Thr = N-methyl-threonine, N-Me-Leu = N-methyl-leucine, N-Me-allo-Ilu = N-methyl-isoleucine, N-Me-4-OMe-Trp = N-methyl-4-methoxy-tryptophan, Ph-threo-Ser = PheMacrocyclic 13LNANaturalProduced by a genetically distinct Nonomuraea species, strain MJM5125Mycobacterium tuberculosis Mycobacterium Tuberculosis H37Rv resistant to cycloserineIC90= < 0.20μg/mlBothVERO cell line52 % bacteria is killed No cytotoxicityNA NANANANANANA201425409285
antitb_1723SEQ ID NO 3NVTSIHSLLFreeFreeNoneLinear9LNAProtein DerivedFrom the proetins containing mycobacterial CD8 T cell epitopesMycobacterium tuberculosisMycobacterium tuberculosisNAIn vitroPBMcsNANAβ2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice NAIFN-γ release increasesBy CD8 T cell responseNANoneNone2002US 2002/013197
antitb_1724SEQ ID NO 4ELNNALQNLARTFreeFreeNoneLinear12LNAProtein DerivedFrom the proetins containing mycobacterial CD8 T cell epitopesMycobacterium tuberculosisMycobacterium tuberculosisNAIn vitroPBMcsNANAβ2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice NAIFN-γ release increasesBy CD8 T cell responseNANoneNone2002US 2002/013197
antitb_1725SEQ ID NO 7SGSEAYQGVQQKWDAFreeFreeNoneLinear15LNAProtein DerivedFrom the proetins containing mycobacterial CD8 T cell epitopesMycobacterium tuberculosisMycobacterium tuberculosisNAIn vitroPBMcsNANAβ2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice NAIFN-γ release increasesBy CD8 T cell responseNANoneNone2002US 2002/013197
antitb_1726SEQ ID NO 8TATELNNALFreeFreeNoneLinear9LNAProtein DerivedFrom the proetins containing mycobacterial CD8 T cell epitopesMycobacterium tuberculosisMycobacterium tuberculosisNAIn vitroPBMcsNANAβ2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice NAIFN-γ release increasesBy CD8 T cell responseNANoneNone2002US 2002/013197
antitb_1727SEQ ID NO 9RTISEAGQAMFreeFreeNoneLinear10LNAProtein DerivedFrom the proetins containing mycobacterial CD8 T cell epitopesMycobacterium tuberculosisMycobacterium tuberculosisNAIn vitroPBMcsNANAβ2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice NAIFN-γ release increasesBy CD8 T cell responseNANoneNone2002US 2002/013197
antitb_1728SEQ ID NO 10AYQGVQQKWFreeFreeNoneLinear9LNAProtein DerivedFrom the proetins containing mycobacterial CD8 T cell epitopesMycobacterium tuberculosisMycobacterium tuberculosisNAIn vitroPBMcsNANAβ2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice NAIFN-γ release increasesBy CD8 T cell responseNANoneNone2002US 2002/013197
antitb_1729SEQ ID NO 11SEAYQGVQQFreeFreeNoneLinear9LNAProtein DerivedFrom the proetins containing mycobacterial CD8 T cell epitopesMycobacterium tuberculosisMycobacterium tuberculosisNAIn vitroPBMcsNANAβ2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice NAIFN-γ release increasesBy CD8 T cell responseNANoneNone2002US 2002/013197
antitb_1730SEQ ID NO 12SEAYQGVQQKFreeFreeNoneLinear10LNAProtein DerivedFrom the proetins containing mycobacterial CD8 T cell epitopesMycobacterium tuberculosisMycobacterium tuberculosisNAIn vitroPBMcsNANAβ2-microglobulin gene knowckout mice, TAP-1 null mutant mice and HSP-65 immunized mice NAIFN-γ release increasesBy CD8 T cell responseNANoneNone2002US 2002/013197
antitb_1731Seq ID No 10KMHATNHGGGSFreeFreeNoneLinear11LNASyntheticFrom random peptide libraries diplayed on bacteriophage M13Mycobacterium tuberculosisMycobacterium tuberculosis100 μM completely inhibits the cahpaeron activity of Hsp 16.3In vitroMouse bone marrow derive dmacrophages and THP-1NANANone NANAInhibit chaperon activity of heat shock protein 16.3 (Hsp 16.3)Heat shock protein (Hsp 16.3)NoneNone2007US 2007/003721
antitb_1732Seq ID No 22YPHHFKHRHIPIGGGSFreeFreeNoneLinear16LNASyntheticFrom random peptide libraries diplayed on bacteriophage M14Mycobacterium tuberculosisMycobacterium tuberculosis100 μM completely inhibits the cahpaeron activity of Hsp 16.3In vitroMouse bone marrow derive dmacrophages and THP-1NANANone NANAInhibit chaperon activity of heat shock protein 16.3 (Hsp 16.3)Heat shock protein (Hsp 16.3)NoneNone2007US 2007/003721
antitb_1733Seq ID No 1GVENVSWFreeFreeNoneLinear7LNASyntheticFrom random peptide libraries diplayed on bacteriophage M15Mycobacterium tuberculosisMycobacterium tuberculosis100 μM completely inhibits the cahpaeron activity of Hsp 16.3In vitroMouse bone marrow derive dmacrophages and THP-1NANANone NANAInhibit chaperon activity of heat shock protein 16.3 (Hsp 16.3)Heat shock protein (Hsp 16.3)NoneNone2007US 2007/003721
antitb_1734Seq ID No 2KMHATNHFreeFreeNoneLinear7LNASyntheticFrom random peptide libraries diplayed on bacteriophage M16Mycobacterium tuberculosisMycobacterium tuberculosis100 μM completely inhibits the cahpaeron activity of Hsp 16.3In vitroMouse bone marrow derive dmacrophages and THP-1NANANone NANAInhibit chaperon activity of heat shock protein 16.3 (Hsp 16.3)Heat shock protein (Hsp 16.3)NoneNone2007US 2007/003721
antitb_1735Seq ID No 9KMHATNHGGGSFreeFreeNoneLinear11LNASyntheticFrom random peptide libraries diplayed on bacteriophage M17Mycobacterium tuberculosisMycobacterium tuberculosis100 μM completely inhibits the cahpaeron activity of Hsp 16.3In vitroMouse bone marrow derive dmacrophages and THP-1NANANone NANAInhibit chaperon activity of heat shock protein 16.3 (Hsp 16.3)Heat shock protein (Hsp 16.3)NoneNone2007US 2007/003721
antitb_1736Seq ID No 21YPHHFKHRHIPIFreeFreeNoneLinear12LNASyntheticFrom random peptide libraries diplayed on bacteriophage M18Mycobacterium tuberculosisMycobacterium tuberculosis100 μM completely inhibits the cahpaeron activity of Hsp 16.3In vitroMouse bone marrow derive dmacrophages and THP-1NANANone NANAInhibit chaperon activity of heat shock protein 16.3 (Hsp 16.3)Heat shock protein (Hsp 16.3)NoneNone2007US 2007/003721
antitb_1811LL- 37LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESFreeFreeNoneLinear37LCationicNaturalHuman cellsMycobacterium tuberculosisMycobacterium tuberculosis strain H37RvMIC = 5 μMBothNANANAMale BALB/c mice a significant reduction in bacilli loadsNADisruption of cell wall and membranecell wall and membraneNAAntibacterial (P.aeruginosa)201223141114
antitb_1812mouse CRAMPGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPEQFreeFreeNoneLinear34LCationicNaturalMouse cellsMycobacterium tuberculosisMycobacterium tuberculosis strain H37RvMIC = 4 μMBothNANANAMale BALB/c mice a significant reduction in bacilli loadsNADisruption of cell wall and membranecell wall and membraneNAAntibacterial (P.aeruginosa)201223141114
antitb_1813E2 (also known as Bac8c)RIWVIWRRFreeAmidationNoneLinear8LCationicSyntheticNAMycobacterium tuberculosisMycobacterium tuberculosis strain H37RvMIC = 2.6 ± 0.34 g/mLBothNANANAMale BALB/c mice a significant reduction in bacilli loadsNADisruption of cell wall and membranecell wall and membraneNAAntibacterial (P.aeruginosa)201223141114
antitb_1814E6 (also called Sub3)RRWRIVVIRVRRFreeAmidationNoneLinear12LCationicSyntheticNAMycobacterium tuberculosisMycobacterium tuberculosis strain H37RvMIC = 3.2 ± 0.10 g/mLBothNANANAMale BALB/c mice a significant reduction in bacilli loadsNADisruption of cell wall and membranecell wall and membraneNAAntibacterial (P.aeruginosa)201223141114
antitb_1815CP26KWKSFIKKLTSAAKKVVTTAKPLISSFreeFreeNoneLinear26LCationicProtein Derivedderived from a hybrid peptide comprising the amphipathic α -helical Nterminal region of cecropin A and the hydrophobic N-terminal α-helix of the bee venom peptide melittinMycobacterium tuberculosisMycobacterium tuberculosis strain H37RvMIC = 2.1 ± 0.33 g/mLBothNANANAMale BALB/c mice a significant reduction in bacilli loadsNADisruption of cell wall and membranecell wall and membraneNAAntibacterial (P.aeruginosa)201223141114
antitb_1832Hytramycin V(METH-Ala)-(D-Pip)-L-(D-VAL)-Pip-(D-Pip)FreeFreeMETH-ALA= Methylated alanine, D-Pip = piperazic acid moietiesCyclic (Intrachain bond between 1-6)6MixNANaturalFrom Streptomyces hygroscopicus strain ECUM 14046Mycobacterium tuberculosisMycobacterium tuberculosis H37RvMIC = 11.3 μg/mLIn vitroNoneNANANA NANANANANAAntibacterial (Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 29213), Acinetobacter baumannii (ATCC BAA-747), Enterococcus faecalis (ATCC 29212), and Pseudomonas aeruginosa (ATCC 27853)201324224794
antitb_1833Hytramycin V(METH-Ala)-(D-Pip)-L-(D-VAL)-Pip-(D-Pip)FreeFreeMETH-ALA= Methylated alanine, D-Pip = piperazic acid moietiesCyclic (Intrachain bond between 1-6)6MixNANaturalFrom Streptomyces hygroscopicus strain ECUM 14046Mycobacterium tuberculosisClinical isolate, X004439MIC = 9.3 μg/mLIn vitroNoneNANANA NANANANANAAntibacterial (Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 29213), Acinetobacter baumannii (ATCC BAA-747), Enterococcus faecalis (ATCC 29212), and Pseudomonas aeruginosa (ATCC 27853)201324224794
antitb_1834Hytramycin V(METH-Ala)-(D-Pip)-L-(D-VAL)-Pip-(D-Pip)FreeFreeMETH-ALA= Methylated alanine, D-Pip = piperazic acid moietiesCyclic (Intrachain bond between 1-6)6MixNANaturalFrom Streptomyces hygroscopicus strain ECUM 14046Mycobacterium tuberculosisClinical isolate, X004244MIC = 16.9 μg/mLIn vitroNoneNANANA NANANANANAAntibacterial (Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 29213), Acinetobacter baumannii (ATCC BAA-747), Enterococcus faecalis (ATCC 29212), and Pseudomonas aeruginosa (ATCC 27853)201324224794
antitb_1835Hytramycin V(METH-Ala)-(D-Pip)-L-(D-VAL)-Pip-(D-Pip)FreeFreeMETH-ALA= Methylated alanine, D-Pip = piperazic acid moietiesCyclic (Intrachain bond between 1-6)6MixNANaturalFrom Streptomyces hygroscopicus strain ECUM 14046Mycobacterium tuberculosisClinical isolate, X005282MIC = 9.6 μg/mLIn vitroNoneNANANA NANANANANAAntibacterial (Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 29213), Acinetobacter baumannii (ATCC BAA-747), Enterococcus faecalis (ATCC 29212), and Pseudomonas aeruginosa (ATCC 27853)201324224794
antitb_1836Hytramycin V(METH-Ala)-(D-Pip)-L-(D-VAL)-Pip-(D-Pip)FreeFreeMETH-ALA= Methylated alanine, D-Pip = piperazic acid moietiesCyclic (Intrachain bond between 1-6)6MixNANaturalFrom Streptomyces hygroscopicus strain ECUM 14046Mycobacterium tuberculosisClinical isolate, X005319MIC = 19.2 μg/mLIn vitroNoneNANANA NANANANANAAntibacterial (Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 29213), Acinetobacter baumannii (ATCC BAA-747), Enterococcus faecalis (ATCC 29212), and Pseudomonas aeruginosa (ATCC 27853)201324224794
antitb_1837Hytramycin V(METH-Ala)-(D-Pip)-L-(D-VAL)-Pip-(D-Pip)FreeFreeMETH-ALA= Methylated alanine, D-Pip = piperazic acid moietiesCyclic (Intrachain bond between 1-6)6MixNANaturalFrom Streptomyces hygroscopicus strain ECUM 14046Mycobacterium tuberculosisClinical isolate, X001354MIC = 9.7 μg/mLIn vitroNoneNANANA NANANANANAAntibacterial (Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 29213), Acinetobacter baumannii (ATCC BAA-747), Enterococcus faecalis (ATCC 29212), and Pseudomonas aeruginosa (ATCC 27853)201324224794